Related Experiment Video
Updated: May 26, 2026
07:29
Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
Published on: November 12, 2015
Interventional Keratoconus Management: The Critical Imperative for Early Detection and Treatment
Kathryn M Hatch1,2, Eric Donnenfeld3,4, Andrew S Morgenstern5
1Mass Eye and Ear, Boston, MA, USA.
Clinical Ophthalmology (Auckland, N.Z.)
|May 25, 2026
Summary
Early detection and treatment of keratoconus (KC) with corneal cross-linking (CXL) can halt disease progression. This approach offers improved visual function and quality of life, especially with new epithelium-on CXL options.
Area of Science:
- Ophthalmology
- Corneal Ectasia
- Vision Science
Background:
- Keratoconus (KC) is a progressive corneal degeneration impacting vision and quality of life.
- Traditional treatments like glasses, contacts, and penetrating keratoplasty often fail to stop KC progression.
- Early diagnosis is crucial as KC significantly affects patients' lives.
Purpose of the Study:
- To highlight the challenges in detecting early-stage keratoconus.
- To advocate for early identification and treatment of subclinical KC.
- To emphasize the benefits of corneal cross-linking (CXL) in halting disease progression.
Main Methods:
- Review of current understanding of keratoconus progression and treatment limitations.
- Discussion of the paradigm shift introduced by corneal cross-linking (CXL).
- Exploration of emerging technologies for early KC detection and the role of epithelium-on CXL.
Main Results:
- Corneal cross-linking (CXL) stabilizes the degenerative process in keratoconus.
- CXL improves both structural and functional outcomes, leading to long-term visual stability.
- Early intervention with CXL offers the greatest long-term benefit, particularly in subclinical cases.
Conclusions:
- Corneal cross-linking (CXL) represents a significant advancement in keratoconus management.
- Early detection and timely CXL treatment are imperative for optimal patient outcomes.
- Collaboration among eye care professionals is essential to implement new technologies for early KC identification and referral.
Related Concept Videos
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:25Glaucoma: Overview
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...